EMERGENT BIOSOLUTIONS INC. Accrued Income Taxes, Noncurrent
EMERGENT BIOSOLUTIONS INC. (EBS) had Accrued Income Taxes, Noncurrent of $11.20 million as of 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Notes
us-gaap:AccruedIncomeTaxesNoncurrent · last filed 2019-02-22
- 2018-12-31: Accrued Income Taxes, Noncurrent $11.20M.
- 2018-09-30: Accrued Income Taxes, Noncurrent $12.50M.
- 2018-06-30: Accrued Income Taxes, Noncurrent $12.50M.
- 2018-03-31: Accrued Income Taxes, Noncurrent $12.50M.
| Period end | Accrued Income Taxes, Noncurrent |
|---|---|
| 2018-12-31 | $11.20M 10-K · filed 2019-02-22 |
| 2018-09-30 | $12.50M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $12.50M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $12.50M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $12.50M 10-K · filed 2019-02-22 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |